STARLIMS Announces Follow-On Contract With Leading Clinical Research Organization

HOLLYWOOD, Fla., Dec 12, 2007 — STARLIMS Technologies Ltd. (Nasdaq:LIMS), a leading provider of laboratory information management systems (LIMS), today announced an $800,000 follow-on order from a leading contract research organization (CRO) providing clinical research services to pharmaceutical, biotechnology, and medical device companies around the world.

In 2007, STARLIMS will record a total of $1 million in revenue from this customer with the current $800,000 sale covering licenses for STARLIMS Version 10 software. The STARLIMS V10 software will be implemented in multiple laboratory sites throughout the customer’s clinical laboratory network in North America, Europe and Asia Pacific. The current license order follows an initial $300,000 license and services contract which was signed in the third quarter of 2006 and implemented in 2007. Upon the successful completion of the initial project, the customer elected to purchase the additional licenses for a global roll-out of STARLIMS V10.

“We are very pleased to have a leading CRO embrace our web-based technology and decide to standardize their global laboratory operations on our STARLIMS V10,” said Jeff Ferguson, Chief Operating Officer at STARLIMS. “This is another example of our ability to expand into the clinical laboratory information systems market and address the complex needs of these diverse customers. We continue to receive strong interest in STARLIMS’s solutions for clinical labs and see this market as a significant growth opportunity.”


STARLIMS Technologies Ltd. (Nasdaq:LIMS) is a leading provider of laboratory information management systems (LIMS), with over 20 years of LIMS experience. The Company’s flagship product, STARLIMS(r), improves the reliability of laboratory sampling processes, supports compliance with domestic and international regulations and industry standards, and provides comprehensive reporting, monitoring and analysis capabilities. STARLIMS software is used for quality assurance and control, testing and monitoring, and research and development in government, manufacturing and life sciences organizations. With operations in the United States, Canada, the United Kingdom, Israel and Hong Kong, the company serves over 500 organizations in 40 countries. For more information, please see